Patient engagement in practice

“Find research and make it your own” – an interview with Regina Greer-Smith

by Danielle Barron · June 15, 2018

Interview with Regina Greer-Smith, 2018 Clinical Trials Engagement Innovator and a Member of the PFMD Board.  Patient engagement may be coming to the fore in medicine and research but just who are the patients that clinicians and...

Patient engagement in practice

Launch of new patient engagement tool. Danish group piloting PFMD’s practical guide to patient engagement

by Gary Finnegan · May 30, 2018

Interview with Søren Eik Skovlund, chief consultant and senior scientist at Region North Jutland of Denmark, PFMD Collaborator and Core Team Member.   The launch of Patient Focused Medicines Development’s (PFMD) new Patient...

Patient engagement in practice

How patients’ voices can change drug approval

by Gary Finnegan · May 28, 2018

Consulting patients early and often can help regulators understand how medicines users view risk, benefit and quality of life The case of Lotronex (alosteron), a medicine for the management of severe irritable bowel syndrome (IBS),...

The impact of patient engagement

Patient-focused medicines development: ‘From talk to action’

by Roxana Radu · May 25, 2018

Author: Dr Lode Dewulf, Chief Patient Officer at Servier and a Member of the PFMD Board.  Workshop at DIA conference focuses on several initiatives making patient engagement happen Today, no pharmaceutical conference is complete without...

PFMD partners & projects

5 Minutes with…Begoña Nafría Escalera, Hospital Sant Joan de Déu

by Gary Finnegan · May 17, 2018

As part of our series to help the patient engagement community get to know one another, we spoke to Begoña Nafría Escalera, Patient Engagement in Research Coordinator, Hospital Sant Joan de Déu, Barcelona You recently presented the PFMD...

Patient engagement in practice

FDA’s commitment to incorporating the patient voice into their decision-making process

by Danielle Barron · May 8, 2018

The US Food and Drug Administration recently issued an update to their implementation plan, titled “Benefit-Risk Assessment in Drug Regulatory Decision-Making.” The document, which provides an overview of the steps the FDA has taken...

The impact of patient engagement

Integrating patient insights – challenges and opportunities

by Danielle Barron · April 19, 2018

Interview with Anke Holtorf, Managing Director, Health Outcomes Strategies, GmbH on the subject of patient involvement in pharmaceutical market access.   Patients are playing an increasingly powerful part in market access, and this was...

Patient engagement in practice

5 minutes with… Karlin Schroeder from Parkinson’s Foundation

by Gary Finnegan · April 17, 2018

As part of a new series to help the patient engagement community get to know one another, we interviewed Karlin Schroeder, Senior Public Involvement Manager at Parkinson’s Foundation. What are the biggest challenges to widespread...

Tools for patient engagement

Are you and your projects on the map?

by Roxana Radu · April 9, 2018

SYNaPsE, your tool for meaningful patient engagement, has achieved impressive exponential growth!  With 225 initiatives, 223 organisations and 870 users, SYNaPsE is becoming the go-to resource for all PE experts and enthusiasts. In...

PFMD partners & projects

Share4Rare advancing the agenda for rare disease patients

by Roxana Radu · April 9, 2018

Share4Rare is a new platform that moves patients centre-stage and opens new opportunities for patient engagement. The online platform is currently in development in partnership with The Synergist – the organisation that host PFMD –...

Tools for patient engagement

New FDA guidance document

by Roxana Radu · April 9, 2018

PFMD have taken time to respond to the recent Food and Drug Administration (FDA) open consultancy and subsequent update on its Benefit-Risk Assessment in Drug Regulatory Decision-Making. We believe the document offers clarity, is...

PFMD partners & projects

New members joining the PFMD partnership

by Roxana Radu · April 9, 2018

Our community continues to grow. This year already we have welcomed Sheffield Biomedical Research Centre and Sant Joan de Déu Research Foundation (FSJD) into the PFMD family. Our rapid expansion is evidence of the growing momentum behind...